Plenary – Lenalidomide plus RCHOP in DLBCL

Prof Andy Davies (Southampton, UK) discusses 2 important abstracts presented in the plenary session at ICML looking at whether there was a benefit to adding lenalidomide to RCHOP for patients with DLBCL as well as other hot topics in B cell lymphoma.

Written by Esther Drain.